Analysis By Mariah Campoy, PA-C, Doctor of Medical Science Candidate
The rising prevalence of chronic diseases such as obesity, type 2 diabetes, and cardiovascular disease has intensified scrutiny over the role of ultra-processed foods (UPFs) in public health.1 These manufactured products, often high in added sugars, sodium, unhealthy fats, and artificial additives, have been strongly associated with negative health outcomes.1 For the purpose of this analysis, unhealthy UPFs will refer to those containing excessive levels of added sugars, sodium, and unhealthy fats. Despite substantial evidence linking unhealthy UPFs to adverse health effects, many consumers remain unaware of these risks due to misleading packaging and marketing practices. In response, the US Food and Drug Administration (FDA) has proposed enhanced labeling regulations to increase transparency and ensure that consumers have clear, accessible information on the potential health risks of certain processed foods. While food manufacturers and their advocates argue that these regulations infringe upon personal autonomy and industry freedoms, their opposition may be influenced by economic interests, as many of these products serve as significant revenue drivers.2 The central issue lies in balancing consumer choice with public health protection. Recognizing that not all UPFs are inherently harmful, labeling regulations aim to highlight those products that, when consumed in excess, are linked to poor health outcomes. Providing clear, evidence-based information empowers consumers to make informed dietary choices rather than restricting their autonomy. This analysis argues that the imperative to protect public health justifies enhanced labeling requirements, as they ultimately serve the greater good while preserving individual choice and autonomy.
To enhance label requirements, the FDA has proposed front-of-package (FOP) labeling regulations, which would require products high in sugar, sodium, and saturated fat to display clear warning labels.3 Countries such as Chile and Mexico have already implemented similar regulations, leading to measurable declines in the purchase of unhealthy products.4 Such policies encourage consumers to make healthier dietary choices and incentivize food manufacturers to reformulate their products to meet healthier nutritional standards. The fundamental goal of the FDA’s proposed regulations is not to restrict personal choice but rather to ensure that individuals are making informed dietary decisions. Current food labeling practices are often complex, inconsistent, and misleading, making it difficult for consumers to assess the true nutritional value of the foods they purchase. Studies indicate that most consumers struggle to interpret traditional nutrition labels, particularly in distinguishing between natural and added sugars, sodium content, and portion sizes.5 By simplifying and clarifying nutritional information, the new labeling requirements enhance consumer autonomy rather than infringe upon it. Individuals retain the right to purchase and consume whatever foods they prefer, but they do so with a full understanding of the potential health risks. Additionally, there is strong public support for greater transparency in food labeling. A recent study found that FOP labeling on sugar sweetened beverages led to 20% less purchasing when compared to control, which showed the labeling improved their understanding of health harms.6 The implementation of clear, standardized labeling ensures that consumers are not being misled by marketing tactics, which often downplay or disguise unhealthy ingredients.
Despite the public health benefits of enhanced food labeling, opposition from the food industry remains strong. Manufacturers argue that requiring FOP warnings infringes upon industry freedoms, as it forces companies to add government-mandated labels to their products.9,10 However, given the substantial financial burden that preventable chronic diseases place on the US healthcare system, the need for public health intervention outweighs concerns over corporate autonomy. According to the Centers for Disease Control and Prevention (CDC), chronic disease and mental health conditions account for 90% of the nation’s $4.5 trillion in annual healthcare expenditures.7 Additionally, research has linked unhealthy UPFs to mental health disorders, such as depression and anxiety, which may be exacerbated by poor dietary patterns and obesity.8 Addressing these diet-related health crises through clear, evidence-based labeling is a cost-effective strategy that benefits both individual and public health.
Critics further contend that mandatory labeling regulations constitute government overreach and impose financial burdens on manufacturers, potentially leading to higher food prices.9,10 While concerns over government intervention are understandable, public health protection is a core governmental responsibility. The US. government has a precedent of implementing phased regulatory changes, providing manufacturers with sufficient time to reformulate products and update packaging to meet new standards, as seen with past trans fat and nutrition labeling laws.11,12,13 Given this gradual approach, manufacturers should not need to raise food prices to comply with these regulations. Although some companies may experience revenue losses if consumers choose healthier alternatives, reducing the consumption of unhealthy UPFs is necessary to mitigate the healthcare costs and societal burden of chronic disease. Ultimately, while these regulations may affect corporate profits, the long-term benefits to public health far outweigh the economic concerns of the food industry.
Historically, similar regulatory efforts—such as mandatory trans fat labeling and tobacco warning labels—have been met with industry pushback, despite overwhelming evidence of their public health benefits.11,12 However, these policies ultimately led to industry adaptation, with many food companies reformulating their products to meet new health standards. The same trend is likely to occur with UPF labeling, as companies adjust their marketing strategies and develop healthier alternatives to maintain consumer demand. Furthermore, government intervention in food labeling is not a new phenomenon. The Nutrition Labeling and Education Act of 1990 mandated the first standardized nutrition facts panels, despite strong resistance from the food industry at the time.13 Over the years, these regulations have become widely accepted as a necessary tool for consumer education and health protection. The current FDA proposals follow the same principle, prioritizing informed decision-making while maintaining consumer freedom.
A well-designed regulatory approach should seek to balance individual autonomy with public health protection. The FDA’s labeling policies do not eliminate choice but ensure that choices are informed and not manipulated by misleading marketing strategies. Potential compromise solutions that address both public health concerns and industry resistance include gradual implementation periods, allowing manufacturers to adjust packaging and reformulate products; consumer education campaigns to complement new labeling requirements and improve public understanding of nutrition information; and incentivizing reformulation, such as tax breaks for companies that reduce unhealthy ingredients in their products. By preserving consumer freedom while enhancing transparency, these measures create a balanced policy framework that supports both individual rights and the collective public good.
The conflict between individual rights and the public good is at the heart of the FDA’s proposed food labeling regulations. While opponents argue that these policies infringe upon personal autonomy and industry freedoms, the reality is that enhanced food labeling empowers consumers rather than restricting them. The public health benefits of clear and transparent labeling outweigh concerns about government intervention, particularly given the substantial health risks associated with UPF food consumption. Moreover, industry resistance is driven largely by profit concerns rather than genuine advocacy for individual choice. Ultimately, the FDA’s initiative preserves consumer autonomy while ensuring that critical health information is accessible, allowing individuals to make informed dietary decisions that support long-term well-being.
References
- Mendoza K, Barquera S, Tobias DK. Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions. Diabetologia. 2025;68(3):495-506. doi:10.1007/s00125-025-06358-x
- Freedhoff Y, Hébert PC. Partnerships between health organizations and the food industry risk derailing public health nutrition. CMAJ. 2011;183(3):291-292. doi:10.1503/cmaj.110085
- U.S. Food and Drug Administration. FDA Issues Proposed Rule for Front-of-Package Nutrition Labeling. FDA Website. Published 2024. Accessed March 2, 2025. https://www.fda.gov/food/hfp-constituent-updates/fda-issues-proposed-rule-front-package-nutrition-labeling#:~:text=The%20proposed%20FOP%20nutrition%20label
- Taillie LS, Reyes M, Colchero MA, Popkin BM, Corvalán C. An evaluation of Chile’s law of food labeling and advertising on sugar-sweetened beverage purchases from 2015 to 2017: a before-and-after study. PLoS Med. 2020;17(2):e1003015. doi:10.1371/journal.pmed.1003015
- Kim EJ, Ellison B, Prescott MP, Nayga RM. Consumer comprehension of the nutrition facts label: a comparison of the original and updated labels. Am J Health Promot. 2021;35(5):648-657. doi:10.1177/0890117120983128
- Roberto CA, Wong D, Musicus A, Hammond D. The influence of sugar-sweetened beverage health warning labels on parents’ choices. Pediatrics. 2016;137(2):e20153185. doi:10.1542/peds.2015-3185
- Centers for Disease Control and Prevention. Fast Facts: Health and Economic Costs of Chronic Conditions. CDC Website. Published 2024. Accessed March 2, 2025. https://www.cdc.gov/chronic-disease/data-research/facts-stats/?CDC_AAref_Val=https://www.cdc.gov/chronicdisease/about/costs/index.htm
- Samuthpongtorn C, Nguyen LH, Okereke OI, et al. Consumption of ultraprocessed food and risk of depression. JAMA Netw Open. 2023;6(9):e2334770. doi:10.1001/jamanetworkopen.2023.34770
- CBS News. FDA’s “Healthy” Label on Food Faces First Amendment Pushback from General Mills, Conagra, and Kellogg. CBS News Website. Published 2023. Accessed March 2, 2025. https://www.cbsnews.com/news/fda-healthy-label-food-general-mills-conagra-kellogg-first-amendment/
- Stat News. Kellogg’s Faces Pushback Over Mexico’s Nutrition Labeling Rules. Stat News Website. Published August 21, 2023. Accessed March 2, 2025. https://www.statnews.com/2023/08/21/kelloggs-mexico-nutrition-label/
- History.com. The Evolution of Cigarette Warning Labels in the U.S. History Website. Published 2023. Accessed March 2, 2025. https://www.history.com/news/cigarette-warning-labels-smoking
- Downs SM, Thow AM, Leeder SR. The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence. Bull World Health Organ. 2013;91(4):262-269. doi:10.2471/BLT.12.111468
- Institute of Medicine (US) Committee on Examination of Front-of-Package Nutrition Rating Systems and Symbols; Wartella EA, Lichtenstein AH, Boon CS, editors. Front-of-Package Nutrition Rating Systems and Symbols: Phase I Report. Washington, DC: National Academies Press (US); 2010. History of Nutrition Labeling. Accessed March 2, 2025. https://www.ncbi.nlm.nih.gov/books/NBK209859/
